Skip to main content

Advertisement

Table 1 Baseline characteristics

From: Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer

Characteristics N Median (Range)
Total patients 110  
Age 110 74.5 (53–94)
Patients without prior docetaxel exposure 67  
Patients with prior docetaxel exposure 43  
Prostate-specific antigen μg/ml 110 42.3 (2.5–3810)
Alkaline Phosphate U/l 87 101 (9.1–1600)
Albumin g/l 73 3.8 (2.5–4.8)
Hemoglobin g/l 72 12.4 (8.4–15)
Neutrophil to Lymphocyte Ratio 105 3.6 (0.7–18)